Introduction
Dobivamp is a prescription medication that contains the active ingredients Lidocaine, Calcium Dobesilate, Hydrocortisone, and Zinc. It is commonly used to treat various skin conditions, providing relief from pain, inflammation, itching, and irritation.
Uses
Dobivamp is indicated for the management of skin conditions such as hemorrhoids, anal fissures, and pruritus ani (itchy anus). It can also be prescribed for other skin disorders that involve pain, inflammation, or itching, as determined by your healthcare provider.
Dosage and Administration
For adults and children over 12 years of age, a thin layer of Dobivamp should be applied to the affected area three to four times daily, or as directed by your healthcare provider. Wash your hands before and after application. Avoid contact with the eyes, mouth, and broken skin. If you accidentally swallow the cream, seek medical attention immediately.
Mechanism of Action
The active ingredients in Dobivamp work together to provide relief from pain, inflammation, and itching. Lidocaine is a local anesthetic that numbs the area, reducing pain and discomfort. Calcium Dobesilate helps to improve blood flow and reduce inflammation. Hydrocortisone is a corticosteroid that reduces inflammation and itching, while Zinc supports the healing process of the skin.
Side Effects
Dobivamp may cause some side effects, although not everyone experiences them. Common side effects may include temporary redness, itching, or burning at the site of application. These side effects are usually mild and should go away on their own. If you experience any severe or persistent side effects, such as skin rash, swelling, or difficulty breathing, discontinue use and seek medical attention immediately.
Drug Interactions
inform your healthcare provider about all the medications you are currently taking, including over-the-counter drugs, herbal supplements, and vitamins. There are no known significant drug interactions with Dobivamp. However, it is always best to consult with your healthcare provider to ensure the safety and effectiveness of the medication when used in combination with other drugs.
Precautions
Before using Dobivamp, inform your healthcare provider if you have any allergies, especially to Lidocaine, Calcium Dobesilate, Hydrocortisone, or any other medications. Avoid using the cream on open wounds, infected or broken skin, or mucous membranes. If you are pregnant, planning to become pregnant, or breastfeeding, consult your healthcare provider before using this medication.
Storage
Store Dobivamp at room temperature, away from direct sunlight and moisture. Keep the cream out of reach of children and pets. Do not refrigerate or freeze the cream.
Patient Tips
- Follow the dosage instructions provided by your healthcare provider.
- Wash your hands before and after applying the cream.
- Avoid getting the cream in your eyes, mouth, or broken skin.
- If you accidentally swallow the cream, seek medical attention immediately.
- If your symptoms worsen or do not improve after a few days of using the cream, consult your healthcare provider.
- Store the cream in a cool, dry place, away from direct sunlight.
- Do not share the cream with others, even if they have similar symptoms.
- If you have any questions or concerns about using Dobivamp, consult your healthcare provider for further guidance.
Please note that this description, as well as the other content on our website is for educational purposes only. We do not provide medical advice. For specific medical advices, diagnoses and treatment options you should consult with your doctor.
References
- Vitamins and minerals – Calcium (NHS UK) [Accessed 28 Jun. 2024] (online) Available at:
- CLINIMIX N14G30E, solution for infusion (Health Professionals SmPC) Available at:
- Calcium acetate (Drugs.com) [Accessed 6 Jun. 2024] (online) Available at:
- calcium acetate (RX) [Accessed 23 Jun. 2024] (online) Available at:
- Calcium Acetate (MedlinePlus) [Accessed 0 Jun. 2024] (online) Available at:
- Wang Y, Xie G, Huang Y, Zhang H, Yang B, Mao Z. Calcium acetate or calcium carbonate for hyperphosphatemia of hemodialysis patients: a meta-analysis. PLoS One. 2015 Mar 23;10(3):e0121376. doi: 10.1371/journal.pone.0121376. eCollection 2015. [Accessed 29 Jun. 2024] Available at:
Reviews
There are no reviews yet.